Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00941889 · ClinicalTrials.gov registry record · NA
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT00941889: Completed NA study, sponsored by Washington University School of Medicine.
NCT00941889 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00941889, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.
Primary Outcome
Persistence of anal warts will be measured by the presence of any lesions at one month follow-up after surgery. Recurrence of anal warts will be measured by the development of new lesions after one month of follow-up.
Interventions
- DRUG Saline
- DRUG Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT00941889 record still lists
NCT00941889 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00941889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00941889 about?
NCT00941889 is a clinical study titled "The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata". The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.
What is the current status of trial NCT00941889?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2007-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00941889?
The interventions under investigation include: Saline (DRUG), Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine (DRUG).
Who is sponsoring clinical trial NCT00941889?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00941889's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia